Latest Breaking News On - Americas committee for treatment - Page 1 : comparemela.com

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update

EQS-News: Immunic AG: Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittEdna kaplanJessica breuPaula schwartzTrademark officeExchange commissionImmunic inc nasdaqClinical development programsAmericas committee for treatmentDevelopment rd expensesImmunic incRx communications groupDistribution servicesResearch in multiple sclerosisInterim statement

Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc Reports First Quarter 2024 Financial Results and Provides Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanJessica breuPaula schwartzDaniel vittTrademark officePrnewswire immunic inc nasdaqExchange commissionDevelopment rd expensesAmericas committee for treatmentClinical development programsRx communications groupResearch in multiple sclerosisImmunic incSubstantially bolstered balance sheet throughExtending cash runway into

Cannabis Use Disorder Increasing Among Patients With Multiple Sclerosis

A pilot study presented at ACTRIMS is investigating home-based transcranial direct current stimulation as a cannabis use disorder intervention in MS.

United statesNew yorkWest palm beachResearch in multiple sclerosisGrossman school of medicineAmericas committee for treatmentAmericas committeeMultiple sclerosisNew york cityKessler psychological distress scaleAfrican americanPatient determined disease steps

Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS

Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.

United statesKathy zackowskiResearch in multiple sclerosisAmericas committee for treatmentNational ms societyImage creditAmericas committeeMultiple sclerosisWithout bordersAmerican journal

Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds

Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.

United statesDalia rotsteinUniversity of torontoResearch in multiple sclerosisAmericas committee for treatmentAmericas committeeMultiple sclerosisSclerosis concept mapAmerican journalWhite europeanNorthern europeans